Wireless pulmonary artery sensor implantation in a unilateral lung transplant recipient.
CardioMEMS
Heart failure
Lung transplant
Wireless pulmonary artery sensor
Journal
Journal of cardiology cases
ISSN: 1878-5409
Titre abrégé: J Cardiol Cases
Pays: Japan
ID NLM: 101549579
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
09
04
2023
revised:
05
07
2023
accepted:
18
07
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Patients with lung transplantation can have concomitant left ventricular failure which can either precede the lung transplantation or develop after. Implantable wireless pulmonary artery (PA) pressure monitors to guide hemodynamic management in heart failure such as the CardioMEMS device (Abbott, Sylmar, CA, USA) have been shown to improve outcomes. However, in a lung transplant recipient there are unique physiological and practical considerations when contemplating to implant a PA pressure sensor such as safety of implanting the device, choice of site of implantation, accuracy of wedge tracings to calibrate, and exclusion of vascular stenoses post transplantation. We discuss these considerations in the context of a man in his early 60s with a known left lung transplant two years previously who developed worsening heart failure needing invasive monitoring. Right lung PA sensor placement was considered, but on selective pulmonary angiography the right PA was found to be of small caliber and with significant tortuosity. After careful hemodynamic assessment, the PA sensor was implanted in the PA of the transplanted lung which is the first such case to our knowledge. We report the first documented case of an implantable wireless pulmonary artery pressure monitor (CardioMEMs) into a transplanted lung. Device-related complications, such as pulmonary artery injury, infection, and hemoptysis, must be assessed after placement. Given the changes in pulmonary artery pressures after lung transplantation, recalibration of the CardioMEMs device may need to be considered if placed within first year of transplant.
Identifiants
pubmed: 38024115
doi: 10.1016/j.jccase.2023.08.004
pii: S1878-5409(23)00094-4
pmc: PMC10658300
doi:
Types de publication
Case Reports
Langues
eng
Pagination
216-220Informations de copyright
© 2023 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
Lancet. 2021 Sep 11;398(10304):991-1001
pubmed: 34461042
J Heart Lung Transplant. 2019 May;38(5):530-544
pubmed: 30718043
J Am Coll Cardiol. 2019 Dec 10;74(23):2845-2854
pubmed: 31806127
Chest. 1993 Jan;103(1):59-63
pubmed: 8380268
Cardiovasc Diagn Ther. 2018 Jun;8(3):378-386
pubmed: 30057884
Semin Respir Crit Care Med. 2014 Jun;35(3):362-71
pubmed: 25007088
JAMA Cardiol. 2017 Nov 1;2(11):1277-1279
pubmed: 28975249
Lancet. 2011 Feb 19;377(9766):658-66
pubmed: 21315441
J Thorac Cardiovasc Surg. 1993 Aug;106(2):299-307
pubmed: 8341071
JAMA. 2015 Mar 3;313(9):936-48
pubmed: 25734735